7108 Phase II study of IMC-1121B in patients with metastatic renal cell carcinoma (mRCC) following failure of VEGFR-2 tyrosine kinase inhibitor (TKI) therapy: interim results (IMCL CP12–0605/NCT00515697)

✍ Scribed by Garcia, J.A.; Hudes, G.; Choueiri, T.K.; Stadler, W.M.; Wood, L.; Bhatia, S.; Youssoufian, H.; Rowinsky, E.K.; Schwartz, J.D.; Thompson, J.A.

• Book ID: 123486729
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71441-7